Say prostate cancer so komaduan sankarakelan a kanser ed saray lalaki ed interon mundo, ya manga 1.276 milyon so balon kaso nen 2018, ya 7.1% na amin ya kaso na kanser ed saray lalaki.
Say bilang na ompapatey lapud prostate cancer et atagey met, ya tinantya ya 37,005 so inatey ed interon mundo nen 2018.
Balet, nanduruma so bilang na ompapatey ed prostate cancer diad nanduruman rehyon, a say Western Africa so komaliman sankatageyan so posibilidad ya ompatey ed prostate cancer diad interon mundo, tan say Nigeria so sankabalegan so populasyon tan ekonomya to ed sayan rehyon.
Diad Nigeria, say prostate cancer so sankarakelan tan sankamateyan a klase na kanser ed lalaki, a tinantya a 32.8 so awalaan tan 16.3 so inatey ed kada 100,000 a lalaki.
Masulok iyan doble na bilang na ompapatey ed North America.
Say atrasadon impakaamta ed sakit, limitadon pambilay parad pan-screening tan pan-detect, tan say agpakakakarga na rekord tan report na saray kaso so sengegan na atagey a bilang na ompapatey ed Nigeria.
Diad Estados Unidos, say prostate cancer so komadua ed saray kaslakan a pansesengegan na ipapatey na saray lalaki lapud kanser, a manga 40,0000 a lalaki so ompapatey ed satan a sakit kada taon.
Say bilang na ompapatey ed prostate cancer et kalkalnan ondaraiset manlapu la nen kagapo na dekada 1990, balet siansia nin manunan pakakaaburidoan na totoo.
Diad interon mundo, say prostate cancer et makapatey a sakit, lalo la ed saray lugar ya daiset so tambal tan panag-eksamin.
Balet, no naamtaan tan natambal a tampol so sakit, mas marakep so pansumpalan tan nabawasan so ipapatey.
Nakata S, Takahashi H, Ohtake N, Takei T, Yamanaka H: Trends and characteristics in prostate cancer mortality in Japan. Int J Urol. 2000, 7 (7): 254-7.
Pishgar F, Ebrahimi H, Saeedi Moghaddam S, Fitzmaurice C, Amini E: Global, Regional and National Burden of Prostate Cancer, 1990 to 2015: Results from the Global Burden of Disease Study 2015. J Urol. 2018, 199 (5): 1224-1232.
Cai Q, Chen Y, Zhang D, Pan J, Xie Z, Xu C, Li S, Zhang X, Gao Y, Hou J, Guo X, Zhou X, Zhang B, Ma F, Zhang W, Lin G, Xin Z, Niu Y, Wang Y: Estimates of over-time trends in incidence and mortality of prostate cancer from 1990 to 2030. Transl Androl Urol. 2020, 9 (2): 196-209.
Feletto E, Bang A, Cole-Clark D, Chalasani V, Rasiah K, Smith DP: An examination of prostate cancer trends in Australia, England, Canada and USA: Is the Australian death rate too high? World J Urol. 2015, 33 (11): 1677-87.
Taksler GB, Keating NL, Cutler DM: Explaining racial differences in prostate cancer mortality. Cancer. 2012, 118 (17): 4280-9.
['Disclaimer: medikal']
['Sayan website et parad edukasyon tan impormasyon labat tan agmangiter na medikal a simbawa odino propesyonal a serbisyo.']
['Say impormasyon ya intarya so agnepeg ya usaren pian nadiagnose odino natambal so problema ed bunigas odino sakit, tan saramay manaanap na personal a medikal a simbawa so nepeg a mankonsulta ed sakey a lisensiadon doktor.']
['Tandaan ya say neural network ya uusaren pian naebatan iray tepet et aliwan susto no bilang so usaren, singa bilang na totoon walay sakit da.']
['Lawas onkerew na simbawa ed doktor odino arum nin kualipikadon health provider nipaakar ed sakit mo. Agmon balot ibabaliwala so simbawa na doktor odino itutunda itan lapud walay abasam ed sayan website. No iisipen mon walay emergency mo, tawagan so 911 odino onla kan tampol ed sankaasinggeran ya emergency room.']
['Disclaimer: copyright']
['Say Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (say DMCA) et mangiiter na legal a tulong ed saray akankayarian na copyright no manisia ran say materyal ya walad Internet et onkokontra ed kanepegan da. ']
['No manisia ka ya walay karga odino materyal ya in-post ed website odino diad saray serbisyo mi ya onkokontra ed copyright mo, sarag mo (odino say representative mo) ya ipawit ed sikami so sakey a sulat ya mangibagan ekalen mi so karga odino materyal, odino i-block so access ed satan. ']
['Saray anunsio et nepeg ya ipawit ed sulat panamegley na e-mail (nengnengen so "Contact" section parad e-mail address). ']
['Unong ed DMCA, kaukolan ya ipila ed pakabat mo so onggendan ya impormasyon: (1) deskripsion na copyrighted ya kimey ya ibabagan inabuso; (2) deskripsion na ibabagan inabuso tan impormasyon ya magenap pian naromog mi itan; (3) impormasyon pian nakontak ka, kaiba lay address, numero na telepono, tan email address mo; (4) deklarasyon mo ya talagan papanisiaan mon say inusar mo et ag-inabuloyan na akankayaryan na copyright, odino na ahente to, odino na anggan anton ley; ']
['(5) sakey a deklarasyon ya pinirmaan mo, ya agmo aabuloyan ya palso so ibabaga na satan, ya susto so impormasyon ed samay inyanunsio tan walay autoridad mon mangipaakseb ed saray copyright ya ibabagan asakitan; ']
['tan (6) sakey a pisikal odino electronic signature na akankayarian na copyright odino sakey a toon naikdan na autoridad ya onkiwas parad akankayarian na copyright. ']
['No agmo ipila so amin ya impormasyon ed tagey, nayarin naabala so pangasikaso ed reklamo mo.']
['Kontak']
['Ipangasin ipawit ed sikami so antokaman a tepet / suhestion yo.']
How deadly is prostate cancer?
Prostate cancer is the second most common cancer in men worldwide, with an estimated 1.276 million new cases reported in 2018, representing 7.1% of all cancer cases in men.
The mortality rate for prostate cancer is also high, with an estimated 37,005 deaths worldwide in 2018.
However, the mortality rate varies greatly by region, with Western Africa having the fifth-highest risk for prostate cancer mortality in the world, and Nigeria having the largest population and economy in this region.
In Nigeria, prostate cancer is both the most common and most deadly cancer for men, with an estimated 32.8 cases and 16.3 deaths per 100,000 men.
This is more than double the death rate in North America.
Late detection of the disease, limited resources for screening and detection, and decreased documentation and reporting of cases contribute to the high mortality rate in Nigeria.
In the United States, prostate cancer is the second most common cause of cancer death in men, with approximately 40,0000 men dying from the disease each year.
The prostate cancer death rate has been slowly decreasing since the early 1990s, but it remains a significant health concern.
Overall, prostate cancer is a deadly disease, particularly in regions with limited access to medical care and screening resources.
However, early detection and treatment can significantly improve outcomes and reduce mortality rates.
Disclaimer: medical
This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.
The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.
Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.
Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.
Disclaimer: copyright
The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.
['Nipaakar ed']
['Uusaren na BioMedLib iray automated computer (machine-learning algorithms) pian makapanggaway parepareho iran tepet tan ebat.']
['Igapo tayo ed 35 milyon ya biomedical ya publikasyon na PubMed/Medline.']
